4,982 Shares in The Clorox Company (NYSE:CLX) Acquired by Centiva Capital LP

Centiva Capital LP acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 4,982 shares of the company's stock, valued at approximately $812,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Mizuho Securities USA LLC increased its holdings in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Nuance Investments LLC increased its stake in Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock worth $218,035,000 after acquiring an additional 960,094 shares during the last quarter. Van ECK Associates Corp raised its holdings in shares of Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock worth $237,372,000 after acquiring an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Clorox by 14.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company's stock valued at $131,200,000 after acquiring an additional 120,716 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Clorox by 11.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company's stock valued at $109,483,000 after acquiring an additional 85,529 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 1.6 %

NYSE:CLX traded down $2.77 during midday trading on Friday, hitting $166.97. The stock had a trading volume of 1,217,064 shares, compared to its average volume of 1,054,507. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock has a 50-day moving average of $163.50 and a 200 day moving average of $150.49. The company has a market capitalization of $20.67 billion, a price-to-earnings ratio of 58.18, a PEG ratio of 3.10 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.49 earnings per share. The business's revenue for the quarter was up 27.0% on a year-over-year basis. As a group, sell-side analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent research reports. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research note on Friday, October 11th. Barclays upped their target price on shares of Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and increased their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Citigroup boosted their price objective on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, DA Davidson raised their price objective on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox has a consensus rating of "Hold" and an average price target of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.